Cargando…

2147. Design of a Ligand-Targeted Immunotherapy for Treatment of Influenza Virus Infections

BACKGROUND: Nearly 10% of world’s population is affected by influenza virus infections and more than 26 million Americans were infected during the 2022-2023 flu season, with 290,000-640,000 patients requiring hospitalization. While flu vaccines are widely available, they were only 36% effective duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahriar, Imrul, Campbell, Charity L, Kanduluru, Ananda K, Srinivasarao, Madduri, Low, Philip S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678547/
http://dx.doi.org/10.1093/ofid/ofad500.1770

Ejemplares similares